MelissaDelbelloMD

Psychiatry • Cincinnati, OH

Child & Adolescent Psychiatry

Professor, Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine

Join to view full profile

Dr. Delbello is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Delbello's full profile

Already have an account?

Office
234 Goodman St
Suite 3200
Cincinnati, OH 45219
Phone+1 513-558-7700

Fax+1 513-558-0877

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Child and Adolescent Psychiatry, 1998 - 2000
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1995 - 1999
University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1995 - 1998
University of Rochester School of Medicine and DentistryClass of 1995

Certifications & Licensure

OH State Medical License 1996 - 2025
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents Start of enrollment: 2003 Jun 01
Completed
Phase 3
A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder Start of enrollment: 2005 Oct 01
Completed
Phase 3
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania Start of enrollment: 2006 Nov 01
Completed
Phase 4
Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine Start of enrollment: 2006 Dec 01
Completed
Phase 4
Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults Start of enrollment: 2008 Apr 01
Completed
Phase 4
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults Start of enrollment: 2008 Dec 01
Completed
Phase 4
Multimodal Neuroimaging of Treatment Effects in Adolescent Mania Start of enrollment: 2009 Mar 01
Completed
Not Applicable
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania Start of enrollment: 2009 Jun 01
Completed
Phase 2
Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
Mindfulness Based Cognitive Therapy for Youth With Anxiety at Risk for Bipolar Disorder Start of enrollment: 2013 Jul 01
Completed
Not Applicable
Mindfulness in Mood Dysregulated Youth Start of enrollment: 2014 Mar 01
Completed
Not Applicable
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01
Completed
Phase 2, Phase 3
Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30
Completed
Phase 3
Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder Start of enrollment: 2015 Aug 21
Completed
Phase 3
Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs Start of enrollment: 2015 Dec 01
Completed
Phase 4
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® Start of enrollment: 2014 Jun 01
Terminated
Phase 2, Phase 3
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Brain structural connectomic topology predicts medication response in youth with bipolar disorder: A randomized clinical trial.
Du Lei, Kun Qin, Wenbin Li, Walter H L Pinaya, Maxwell J Tallman
Journal of Affective Disorders. 2025-02-15
The Impact of the Psychiatry Medical Student Scholars Program.
Wan Y Kwok, Niki Moftakhor, Peirce Johnston, Brian Evans, Melissa DelBello
Academic Psychiatry. 2024-12-01
A Double-Blind, Placebo-Controlled Study of Adjunctive Topiramate in Adolescents With Co-Occurring Bipolar and Cannabis Use Disorders.
Jenni E Farrow, Melissa P DelBello, Luis R Patino, Thomas J Blom, Jeffrey A Welge
JAACAP Open. 2024-12-01

Journal Articles

Discrete Patterns of Cortical Thickness in Youth with Bipolar Disorder Differentially Predict Treatment Response to Quetiapine but Not Lithium
Melissa P DelBello, Caleb M Adler, Jeffrey R Strawn, Fabiano G Nery, Nature

Authored Content

Clinical Relevance Versus Statistical Significance: DelBello and Colleagues Respond to EditorialApril 2018
Efficacy and Safety of Lurasidone in Children and Adolescents with Bipolar I Depression: A Double-Blind, Placebo-Controlled StudyOctober 2017
Efficacy and Safety of Lurasidone in Children and Adolescents with Bipolar I Depression: A Double-Blind, Placebo-Controlled StudyOctober 2017

Press Mentions

Neuroimaging & Artificial Intelligence Help Detect Brain Changes, Development of Future Disorder in Children of Bipolar ParentsApril 16th, 2024
Comorbid Substance Use Disorders Among Youth with Bipolar Disorder: Opportunities for Early Identification and PreventionAugust 18th, 2009

Grant Support

Multimodal Neuroimaging Of Treatment Effects In Adolescent ManiaNational Institute Of Mental Health2009–2012
Neurochemical Effects Of Omega-3 Fatty Acids In Adolescents At Risk For ManiaNational Institute Of Mental Health2009–2011
Topiramate For Co-Occurring Alcohol Use And Bipolar Disorders In AdolescentsNational Institute On Alcohol Abuse And Alcoholism2008–2009
Topiramate For Co-Occurring Cannabis Use And Bipolar Disorders In AdolescentsNational Institute On Drug Abuse2006–2008
Brain Abnormalities In Adolescent Bipolar DisorderNational Institute Of Mental Health2002–2006